Artiklar

{{ window.visitor.ipAccess.corporateClient.name }}
Welcome to our Corporate client solution

Your IP is registered with the company mentioned above and provides access to Life Science Sweden.
Click here to go to sign-up

Sortering: Sida Sida av 1

Nytt AI-verktyg ska hjälpa forskare förstå varför läkemedel misslyckas
Sep. 15
Ett nytt AI-verktyg ska lösa ett av läkemedelsutvecklingens stora utmaningar: patienter som inte svarar på sina behandlingar. Genom att koppla samman stora mängder biomedicinsk data hoppas svenska Mavatar kunna ge forskare nya svar – snabbare.
”Sverige riskerar tappa forskartalanger – dags att bygga broar”
Sep. 04
Debatten om arbetskraftsinvandring är het i Sverige. Men när vi diskuterar kvoter och restriktioner missar vi en avgörande aspekt: Vad händer med de internationella forskare, doktorander och postdocs, som redan finns här, och som utgör en central del av vår spetskompetens inom life science? Om det resonerar Tina Persson i en debattartikel.
The scientist behind Novo Nordisk's obesity success: “I never stopped believing in GLP-1”
Maj 19
the game," says Lotte Bjerre Knudsen, Chief Scientific Advisor at Novo Nordisk.
Health politician Lina Nordquist: ”I find it hard to be idle”
Mar. 03
She is the pharmacist and researcher who grew tired of the breakthroughs that never materialised and knowledge that never seemed to reach patients, so she decided to make a change from within. Life Science Sweden meets Lina Nordquist, Member of Parliament for the Liberals and their spokesperson on healthcare policy, to have a conversation about reality, politics, and the need for writing.
She is CSL Behring's new Nordic General Manager
Jan. 28
Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.
Life science trends 2025 – Part 1 obesity drugs
Jan. 10
More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs. But the next big breakthrough in obesity has a different mechanism of action, writes Samuel Lagercrantz in the first article in a series of trend insights for 2025. Today: obesity.

Resultat per sida: Sida Sida av 1

BREAKING

{{ article.headline }}

0.078|instance-web04